Human X-linked blue-cone monochromacy (BCM), a disabling congenital visual disorder of cone photoreceptors, is a candidate disease for gene augmentation therapy. BCM is caused by either mutations in the red (OPN1LW) and green (OPN1MW) cone photoreceptor opsin gene array or large deletions encompassing portions of the gene array and upstream regulatory sequences that would predict a lack of red or green opsin expression. The fate of opsin-deficient cone cells is unknown. We know that rod opsin null mutant mice show rapid postnatal death of rod photoreceptors. We studied a cohort of 20 BCM patients (ages 5-58) with large deletions in the red/green opsin gene array using in vivo histology with high resolution retinal imaging. Already in the first years of life, retinal structure was not normal: there was partial loss of photoreceptors across the central retina.
Introduction
The human retina has on average 100 million rod photoreceptors that subserve night vision and six million cone photoreceptors responsible for daylight, color and fine spatial vision (Osterberg, 1935; Curcio et al., 1990) . Three cone photoreceptor types with light-absorbing visual pigments of different wavelength sensitivitynamed simply blue (short-wavelength sensitive, S), green (middle-wavelength sensitive, M) and red (long-wavelength sensitive, L)give rise to trichromacy of normal human color vision (Young, 1802; Helmholtz, 1866) . The apoprotein opsins of rods and three types of cones are integral membrane proteins in the photoreceptor outer segments. Four kinds of pigments are thus formed when opsins are covalently linked to the 11-cis-retinal chromophore. Light absorbed by are located on Xq28 and arranged as a head-to-tail tandem array and expression is driven and regulated by specific promoters and a single upstream locus control region (LCR) (Nathans et al.,1986a,b; ). X-linked eye disorders resulting from mutations in the L/M cone opsin gene array range from common color vision deficiencies to severe loss of day vision with nystagmus and macular degeneration (Nathans et al.,1986a; . The latter disorder, named blue-cone monochromacy (BCM; OMIM #303700), is associated with three categories of mutations affecting OPN1LW and OPN1MW loci. Recent imaging analyses of the retina in subjects with two of the mutation types (missense mutations and L/M interchange mutations) reported differences in disease expression between them and raised potential issues with their candidacy for visual restoration by gene augmentation therapy (Carroll et al., 2012) . The third category involving large deletions of the L/M pigment genes and/or deletions upstream of the L pigment gene containing the LCR, however, were not studied with modern methods. These mutations would be expected to result in complete absence of L/M cone opsin expression (Wang et al., 1992) . A clue about possible effects of such mutations came with the finding of abnormal cone mosaics in carrier females (Carroll et al., 2010) . We evaluated the retinal structure and function in BCM caused by such large deletion mutations, and weighed the value and goals of gene augmentation as a therapy for such patients.
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Materials and Methods

Human subjects
Twenty patients (ages 5 to 58 years) with a clinical diagnosis of BCM and mutations in the X-chromosome visual pigment genes were included (Table 1) .
Informed consent or assent was obtained; procedures followed the Declaration of Helsinki and had institutional review board approval. All patients underwent a complete eye examination, genetic analyses as well as specialized tests of retinal cross-sectional structure; subsets of patients were imaged with AOSLO or evaluated with specialized visual function tests.
Genetic analyses
Whole venous blood samples were collected and genomic DNA extracted according to standard procedures. Details are provided in Supplementary Methods.
En face autofluorescence imaging and in vivo microscopy of human retina
Health of the retinal pigment epithelium (RPE) was evaluated with reducedilluminance autofluorescence imaging (RAFI) as published (Cideciyan et al., 2007) .
Near-infrared (NIR) excitation was used to detect melanin granules and shortwavelength (SW) excitation was used to detect lipofuscin granules (Cideciyan et al., 2007; Gibbs et al. 2009 ). Cross-sectional images of the retina were obtained with a spectral-domain optical coherence tomography (SD-OCT) instrument (RTVue-100, Optovue Inc., Fremont, CA). Details are provided in Supplementary Methods.
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Adaptive optics imaging of the photoreceptor mosaic
A previously described adaptive optics scanning laser ophthalmoscope (AOSLO) was used to image each subject's photoreceptor mosaic . Details are provided in Supplementary Methods.
Spectral sensitivity function
Spectral sensitivity functions were measured in normal subjects (n=3, ages 31-50) and BCM P15 using a modified perimeter with methods previously described . Details are provided in Supplementary Methods.
Results
Genetic findings and clinical characteristics of the BCM patients
Pedigrees of the 11 families in this study suggested X-linked inheritance ( Fig.1A) . The clinical diagnosis of all 20 patients was BCM. From early life, there was reduced visual acuity and nystagmus. When there was more specific information (by history) of age of onset or a decline or an increase in nystagmus, this was noted (Table 1) . All but 3 of the patients described light aversion to some degree, leading to coping strategies such as almost continuous wear of sunglasses or squinting. Color vision was abnormal indicating cone dysfunction, but there was detectable S cone function. Electroretinography (ERG) revealed normal or nearly normal rod signals but severely abnormal cone ERGs (Table 1) . 
Genetic analyses identified genomic deletions of various extents at the
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OPN1MW/OPN1LW gene cluster in all 20 BCM patients ( Fig.1B) . In 10 of the families, the deletions encompassed the LCR as well as the OPN1LW promoter. In Family 1, the LCR region was intact but a large (over 45.5 kb) deletion covered all coding exons of the OPN1LW gene as well as the promoter and first coding exon of the OPN1MW gene (Fig.1B) . The types of deletions represented in the 11 families are considered sufficient for the complete loss of expression of the OPN1MW/OPN1LW genes on the X-chromosome (Wang et al., 1992) .
Near normal retinal-macular appearance by en face viewing in most BCM eyes
The traditional clinical view is that BCM is a congenital cone vision disturbance with normal retinal appearance in early life but the possibility of macular degeneration later in life (Weleber, 2002) . En face imaging, performed with reduced-illuminance autofluorescence imaging (RAFI) methods (Cideciyan et al., 2007) , confirmed this clinical impression in our BCM cohort ( Fig.2A) . RAFI assays the health of the retinal pigment epithelium (RPE) -the cellular layer adjacent to the photoreceptors -taking advantage of its naturally-occurring fluorophores melanin and lipofuscin excited by near-infrared (NIR) and shortwavelength (SW) lights (Gibbs et al., 2009) . P1 (age 8) represents the majority of BCM patients who showed a macular appearance indistinguishable from normal with its characteristic higher central intensity on NIR-RAFI and lower central intensity on SW-RAFI ( Fig.2A ). P16 (age 28) together with two other BCM patients (P19,P20; ages 43,55) represent a second group with minor abnormalities consisting of a lack of a distinct foveal hypo-autofluorescence on SW-RAFI and/or 
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Cone photoreceptor cells in BCM diminished already in childhood
Using retinal cross-sectional imaging, we examined the hypothesis that BCM is simply an early-onset cone visual disturbance and only older patients may show macular atrophy. The layer corresponding to photoreceptor nuclei was measured to determine if the photoreceptor cells were intact ( Fig.2B-E ). Scans crossing the fovea along the vertical meridian are shown in a representative normal subject and three BCM patients (Fig.2B ). The photoreceptor outer nuclear layer (ONL) layer, which includes the photoreceptor nuclei and their axons (Lujan et al., 2011) is highlighted. P1 (age 5) and P16 (age 28) showed some differences from the normal (age 29), whereas P4 (age 50) had foveal degeneration with a ~2 mm region missing all photoreceptor nuclei ( Fig.2B ). Quantitation of ONL thickness in all BCM patients indicated there was a central region of abnormal thinning surrounded by normal or near normal thickness at greater eccentricities ( Fig.2C ). At the foveola, which normally is dominated by L/M cones and lacks rods (Borwein et al., 1980; Youdelis and Hendrickson, 1986) , the ONL was abnormally thin in all patients but one (Fig.2D, upper panel) . Younger BCM patients between the ages of 5 and 20 showed a mean foveolar ONL thickness of 60.7 μm (SD=13 μm;; n=12) which is about 60% of normal (mean±SD, 95.7±9.5 µm; n=22, . Older BCM patients, with some exceptions, tended to show increased thinning Page 8 of 47
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Immediately surrounding the foveola (~0.8 mm eccentric), rod as well as cone nuclei normally occupy the ONL. All but the youngest patients showed abnormal ONL thickness at this location ( Fig.2D , middle panel) implying potential involvement of macular rods in addition to cones in the BCM pathology. The highest density of rods in the human retina is located outside the macula at the 'rod hot spot' in the superior retina (~3.5 mm from the foveola), and the ONL at this location is expected to be dominated by rod photoreceptor nuclei (Curcio et al., 1990) . All BCM patients had normal ONL thickness in this rod-dense zone ( Fig.2D , lower panel). When the spatial extent of the central retinal region with abnormal ONL thickness was quantified along the vertical meridian, there was an agerelated expansion from ~3 mm extent (corresponding to ~1.5 mm eccentricity) in the first decade of life to ~4 mm extent in the 4 th decade of life ( Fig.2E ). Assuming circularly isotropic distribution, the ONL abnormality would be expected to cover a substantial proportion of the macula ( Fig.2E , inset).
Abnormal but detectable cone photoreceptor outer segments in BCM
Is the BCM disease sequence like that in human rhodopsin (rod opsin) mutations with photoreceptor outer segment shortening accompanying or Page 9 of 47
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preceding the cell loss (Milam et al., 1998 )? The answer was sought by analyses of the optical coherence tomography (OCT) signals originating from subcellular components of photoreceptors in our BCM cohort.
In the normal central retina immediately eccentric to the foveola, there are five distinct hyperscattering peaks (Srinivasan et al., 2008; Mustafi et al., 2011; Syed et al., 2013) (Fig.3A) . These peaks are thought to correspond to the outer limiting membrane (OLM), ellipsoid region of photoreceptor inner segments (ISe), the contact cylinder between the RPE apical processes and the cone OS tips (COST), apical RPE microvilli and rod outer segment tips (ROST), and basal RPE and Bruch's membrane (RPE/BrM). Comparison of the longitudinal reflectivity profiles (LRPs), the signal underlying the scans, with a previously published model using quantitative histological measurements (redrawn from shows the expected correspondence of scattering peaks and subcellular rod and cone structures at 0.5 and 0.8 mm superior to the foveola (Fig.3C) .
The BCM foveola often shows discrete discontinuities along the ISe band, suggesting abnormality at the inner and outer segment regions of the photoreceptor cells ( Fig.3B, arrowhead) . Existence of these cavitations (Carroll et al., 2012; Leng et al., 2012) does not allow quantitative analyses to be performed in some of the patients at the foveola. Thus, LRPs were analyzed first at 0.5 and 0.8 mm superior to the foveola (Fig.3B This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. the majority of BCM patients, exemplified by P9, showed an intermittently identifiable hyperscattering peak ( Fig.3B , dashed orange bands between ISe and ROST). This peak is where the COST peak would be expected. A model of the BCM retina at the level of the photoreceptor inner and outer segments (using the identities of hyperscattering peaks derived from normal retina) schematizes the interpretation most consistent with the data at the 0.5 and 0.8 mm superior loci ( Fig.3D ). The distance from the ISe peak to the COST peak, representing the length of cone outer segments (COS), was quantifiable in many BCM patients. At 0.5 mm eccentricity, the mean COS length in BCM was 11.2 μm (SD=2.4 μm;; n=12) representing ~40% of normal value (28.1±2.1 µm) ( Fig.3E ). At 0.8 mm eccentricity, the mean COS length in BCM was 10.0 μm (SD=3.1 μm;; n=13) representing ~41% of the normal value (24.2±2.7 µm) ( Fig.3F ). There was no obvious relationship between COS length and age at either eccentricity ( Fig.3E,F) .
In some BCM patients, a COST peak may not have been identifiable either because of a lack of cones or because COS were shorter than the axial resolution of the instrument. There was no obvious age relationship to the identifiability of the COST peak; there were both younger and older patients without a COST peak.
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Abnormally short rod photoreceptor outer segments in BCM
Rod and cone OS lengthening tend to be temporally synchronized during human retinal development (Hendrickson and Drucker, 1992) . We questioned whether the abnormal congenital shortening of the COS in BCM patients could have secondary consequences on the developmental elongation of ROS length.
The distance between hyperscattering LRP peaks ISe and ROST was used to estimate the ROS length in BCM ( Fig.3A-D) .
At 0.5 mm eccentricity, all BCM patients showed abnormally short ROS length; the mean was 26.1 μm (SD=4.5 μm;; n=19) representing ~59% of normal (44.2±3.1 µm) ( Fig.3G ). Similarly at 0.8 mm eccentricity, the mean ROS length was 26.7 μm (SD=3.0 μm;; n=19) representing ~65% of normal (41.0±2.9 µm) ( Fig.3H ). There was no obvious age relationship; both the youngest patients in the first decade of life as well as older patients in the fourth and fifth decades of life showed ROS length shortening of similar extent with the exception of P4, the patient with foveal atrophy. At 3.5 mm superior retinaa locus within the rod hot spot -ROS thickness straddled the lower limit of normal (71 to 90% of mean normal, data not shown) and again there was no obvious age relationship, except for P4.
'Dark' cones in BCM: remnant L/M cones with impaired reflectivity
To define the identity and spatial density of photoreceptors in BCM, AOSLO was used to image along a plane tangential to the retina at the level of the inner segments . The normal photoreceptor mosaic at 1.5 mm This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. eccentricity contains regularly-spaced larger and smaller structures ( Fig.4A, left) .
Under high magnification ( Fig.4C ), the larger structures have a central reflective core surrounded by a darker ring, consistent with normally waveguiding and reflecting bright cones; and the smaller structures are consistent with adjacent rods Cooper et al., 2011; Carroll et al., 2012) . The BCM patient P11 had a different pattern compared to normal at the same eccentricity To support this interpretation, quantitative analyses of the spatial density of photoreceptors were performed at three eccentricities. At 1.5 mm, P11 had 85,734 rods/mm 2 which was normal by imaging (85,785 ± 14,914 rods/mm 2 ) as well as by published histology (94,079 rods/mm 2 , Curcio et al., 1990) (Fig.4D ). At 0.8 and 0.5 mm, normal rod inner segments are difficult to distinguish individually by current non-invasive AOSLO imaging methods due to their size, packing and relatively wide reflectivity profile . Larger rod inner segments combined with lower cone densities in BCM allow quantitation of rod densities near the fovea in these subjects. Rod densities of P6 (62,812 and 57,344 rods/mm 2 at 0.8 and 0.5 mm, respectively) and P11 (70,156 and 53,594 rods/mm 2 at 0.8 and 0.5 mm, respectively) were normal or near normal based on published histology (73,600 and 51,853 rods/mm 2 at 0.8 and 0.5 mm, respectively, Curcio et al., 1990) .
The spatial density of all cones (both bright and dark) in BCM (4351 and 5128 cones/mm 2 in P6 at 0.8 and 0.5 mm, respectively; 4194, 4999 and 6065 cones/mm 2 in P11 at 1.5, 0.8 and 0.5 mm, respectively) were ~25 % of normal by imaging or by histology (Curcio et al., 1990) (Fig.4D-F) . Consistent with the assumption that a healthier S cone population corresponds to the bright cones in BCM, their spatial densities (1865 and 2486 cones/mm 2 in P6 at 0.8 and 0.5 mm, respectively; 1864, 2499 and 2022 cones/mm 2 in P11 at 1.5, 0.8 and 0.5 mm, respectively) were similar to that expected from a 7% estimate of the total cone population (Hofer et al., 2005) imaged by AO or direct S cone density estimates from histology (Curcio et al., 1991) (Fig.4D-F greater instability of fixation did not allow reconstruction of a wide angle montage required to make quantitative measurements at known retinal eccentricities.
AOSLO imaging results taken together with OCT provided further evidence that BCM patients have a lower cone density than that seen in normals, but a higher total cone density than would be expected for just the S cone submosaic, indicating the existence of a remnant L/M cone population in BCM.
Retinal structure at the BCM foveola
The foveola refers to a region at the center of the fovea packed with L/M cones and lacking rod photoreceptors (Borwein et al., 1980; Youdelis et al., 1986) .
Foveola is thus a key retinal location to answer questions about L/M cones in BCM.
On optical cross-section of the normal foveola, the number of hyperscattering peaks distinguishable distal to the hyposcattering ONL trough are reduced from five to four consistent with the lack of the ROST peak ( Fig.5A) ; notably, this feature is only observed when the scan is obtained through the exact cone-only region. Comparison of the normal foveolar LRP with a previously published model using quantitative histological measurements (redrawn from shows the correspondence of scattering peaks and subcellular structures at the foveola (Fig.5C ). The peaks are thought to correspond to the OLM, ISe, the interface at or near the apical RPE microvilli and COST, and the interface near the basal RPE and BrM.
Quantitative analyses of the foveola were possible in six BCM patients (P2, P6, P8, P11, P15 and P17; ages 8-33) that demonstrated a partially intact ISe Page 15 of 47
Human Gene Therapy
Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy (doi: 10.1089/hum.2013.153) band at this location ( Fig.3B ). Similar to the 0.5 and 0.8 mm loci in BCM and normal subjects, but unlike the foveolar scans in normals, there were five hyperscattering peaks detectable at the foveola of these BCM patients. Of note was the small but identifiable hyperscattering peak immediately distal to ISe band in addition to the pair of larger hyperscattering peaks (Fig.5B ). Such a scattering signature would be consistent with an admixture of cone photoreceptors with shorter COS as well as a second type of photoreceptors (likely rods) with longer outer segments (OS) (Fig.5D ). In the six BCM patients with retained foveolar structure, the COS length ranged from 8.5 to 14.5 µm, which is ~30% of normal COS length at the foveola (38.1±2.7 µm). The longer OS length ranged from 21 to 35 µm (Fig.5E ).
AOSLO images of the normal fovea show a contiguous mosaic of cones that decrease in diameter and increase in density towards the foveola (Fig.5F ) as expected from cone packing (Curcio et al., 1990) . BCM patients showed a severely disrupted foveal mosaic, consisting of a ring of sparsely packed, highly reflective bright cones and a second population of weakly reflecting photoreceptors which were present throughout the foveola (Fig.5F ). The bright cones presumably correspond to S cones and the central region lacking bright cones defines the extent of the S-cone free zone at the center of the foveola; this has been noted in other patients with BCM (Carroll et al., 2012) . The weakly reflecting cells may comprise both remnant L/M cones and rods, though it was not possible to differentiate subtypes within this population. The density of these cells 
Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy (doi: 10.1089/hum.2013.153) at the foveola (38,400 cells/mm 2 and 42,400 cells/mm 2 for P6 and P11, respectively) was ~25% of the normal (162,000 cells/mm 2 ).
Evidence for abnormal but detectable L/M cone function in BCM
Lastly we asked whether a subset of structurally retained L/M cones with shortened outer segments could make a contribution to visual perception in BCM patients. Visual function was assessed in P15 at fixation which was located at 0.6 mm supero-temporal to the foveola. P15 was able to view a bright ambient light without squinting. Many BCM patients squint in even modest lighting presumably in order to limit desensitization of their rods by ambient light levels.
Spectral sensitivity was determined under scotopic and photopic conditions. This was achieved by testing under dark-adapted as well as a range of ambient light conditions designed to increasingly desensitize the dominant rod photoreceptor function in order to uncover cone photoreceptor function (Fig.5G ).
Under scotopic conditions, normal and BCM vision were spectrally consistent with rod photoreceptor mediation (Fig.5G, far 
Discussion
Consequences of congenital cone opsin deficiency on cones
A congenital reduction in density or absence of rod opsin in the rod outer segment, as in the rhodopsin knockout mouse, causes loss of outer segment integrity and rapid rod cell death (Humphries et al., 1997; Lem et al., 1999; Liang et al., 2004; Makino et al., 2012) . Should we expect the same consequences for L/M cone photoreceptors as for rods when there is congenital opsin deficiency, such as in BCM with large deletions at the OPN1LW-OPN1MW gene cluster? The many differences between structure and function of rods versus cones make such an extrapolation uncertain (Mustafi et al., 2009) . Cones contain about half as many visual pigment molecules as do rods (Mustafi et al., 2009; Tachibanaki et al., 2001) . Cones, in contrast to rods, do not have separate stacked membranous discs but have a lamellated continuously-connected membrane. The turnover rate of cone outer segments is thought to be less rapid than in rods (Mustafi et al., 2009; Jonnal et al., 2010) . The expectation is that the effects of opsin deficiency on cones could be different than on rods, and this has been bolstered by the clinical impression that BCM may simply be a congenital stationary cone dysfunction with some patients having a degenerative component in later life.
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Human Gene Therapy Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy (doi: 10.1089/hum.2013.153) From the present studies of BCM, we know that there is not only severe congenital cone visual dysfunction but also a reduced number of cones even in the youngest patients studied (as early as age 5 years). Evidence of progressive central retinal cone loss was present in some patients and macular atrophy in later stages, thereby confirming previous observations (for example, Nathans et al., 1999; Ayyagari et al., 1999; Kellner et al., 2004) . This disease pattern does show some resemblance to that in the rhodopsin knockout mouse but it is less cataclysmic. The cone cell reduction detected in early life could represent the end of a rapid post-natal phase of degeneration, and this may be followed by a slowly progressive decades-long phase of further cone loss. Alternatively, congenital cone opsin deficiency may interfere with the protracted post-natal maturation of the human fovea and the BCM retinas may not complete normal high density cone packing in the fovea, which takes years to achieve (Hendrickson et al., 2012) .
In BCM patients with normal retinal lamination at the foveola, there was evidence for some photoreceptors retaining outer segments. At least a subset of these photoreceptors likely corresponds to remnant L/M cones with abnormally shortened outer segments. A small number of rod cells with longer outer segments may also have migrated into the foveola during an incomplete foveal maturation process. Surrounding the foveola, there were shortened but detectable cone outer segments, corresponding to weakly-reflecting dark cone inner segments (Carroll et al., 2004; Cho et al., 2013) . These likely represent remnant L/M cones. Also surrounding the foveola, intermingled with the cones, were slightly shortened rod outer segments and swollen rod inner segments; rod cell density was near normal. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
It is tempting to attribute the minor rod inner and outer segment abnormalities in the central BCM retina to 'stress' from neighboring abnormal cones (Milam et al., 1998; Rossi et al., 2013) , and to make analogies to the secondary cone loss known to occur in rod-specific diseases. The effects of rod loss on cones continue to be explored (Humphries et al., 2012 ) and a rod-derived cone viability factor has been identified (Leveillart and Sahel, 2010); but little is known of the effects of cone loss on rods. It is also possible that defective development is at play because the rod abnormalities are present as early as we measured (Hendrickson et al., 2012) .
Residual L/M cone function in BCM caused by a deletion at the L/M opsin gene cluster
Vision in BCM is classically dominated by rod and S cone photoreceptors (Blackwell and Blackwell, 1957; Blackwell and Blackwell, 1961; ) but existence of a residual amount of L/M cone driven vision has been demonstrated in patients preceding the molecular era (Smith et al., 1983) . Detailed visual function studies defining the extent of residual L/M cone function in molecularly-characterized patients have been rare. Consistent with the classical point of view has been the lack of detectable L/M cone function in three patients: one with a deletion genotype, and two patients with C203R missense mutations (52). On the other hand, residual L or M cone function was found in a 23-year-old patient with the LIAVA type of mutation (Crognale et al., 2004) , which is thought to cause abnormal splicing of exon 3 of the cone opsin gene (Ueyama et al., 2012) , This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. and in several young affected males in a family with a deletion genotype (Mizrahi-Meissonnier et al., 2010) very similar to the genotype of our Family 1. In patient P15, central vision was mediated by rods and S cones under dark-adapted or standard ambient light conditions. Upon desensitization of the rods by a brighter background light, however, residual vision originating from L/M cones was uncovered ( Fig.5 ). Molecular analysis showed that this subject carries a deletion that encompasses the LCR and parts of the proximal L opsin gene. However, at least one intact M opsin gene with a functional proximal promoter is still present.
We hypothesize that low levels of M opsin are expressed in this BCM patient's cone photoreceptors with abnormally shortened outer segments and this enables cone vision to be detected psychophysically.
Searching for an animal model with cone opsin deficiency and cone cell loss for proof-of-concept studies of therapy in BCM
The experimental literature on the role of congenital cone opsin deficiencies in mammals is limited and complex. Ideally, there should be a primate model with a human-like fovea with a high density of cones. Some monkeys are dichromats and may model color vision abnormalities but there are no reports of cone cell reduction as we observed in our BCM cohort. An M-opsin null mutant rat has deficient cone function but there is neither cone loss nor outer segment abnormalities up to 12 months of age. This rat has also been suggested to be a model for common human color blindness (Xie et al., 2010) . Mice are dichromats with cones that may co-express both opsins (Applebury et al., 2000) . This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
An S-cone opsin knockout mouse showed cone dysfunction and disordered or absent cone outer segments in the ventral retina (Daniele et al., 2011) . A conclusion in this study of possible relevance to BCM is that cone photoreceptors, despite reduced cone opsin expression and abnormal cone outer segments, can survive for at least 1.5 years of this animal's life (Daniele et al., 2011) . The results of the current human study point to the need for an animal model which would share sufficient characteristics with the BCM patients for proof-of-concept experiments en route to therapy.
Considerations for future clinical trials in BCM
A gene augmentation therapeutic approach for BCM due to deletion mutations must consider not only the potential for efficacy but also the fragility of these central retinas with residual foveal cone photoreceptors. Previous human trials using gene delivery by subretinal injection have documented loss of foveal outer segments and cone cells after this procedure (Maguire et al., 2008; Hauswirth et al., 2008; Jacobson et al., 2012) . With the specter of further cone cell loss from subfoveal injections or even uncertainty about loss related to the procedure, it may be prudent to consider intravitreal administration of novel vectors, such as has been shown to be effective at transducing photoreceptors in recent reports in mice and at the fovea in a primate (Kay et al., 2013; Dalkara et al., 2013) .
Candidate selection based on pre-enrollment imaging would also be necessary, considering the need to exclude those with macular atrophy. Further
Page 22 of 47
Human Gene Therapy
Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy (doi: 10.1089/hum.2013.153) research work on human BCM is also needed. It must be clarified whether BCM patients with other than deletion mutations are appropriate candidates to be included in future clinical trials aimed at treating residual central cones. A question not posed in the present study is whether the reduced cone cell layer and limited number of cone outer segments in the foveola of our patients can account for the reduced visual acuity. If there is a disproportionate vision loss for the number of residual cone photoreceptors, there is the possibility that the early loss of vision may also have a component of amblyopia or there may be abnormalities of postreceptor wiring in the retina and higher visual pathways (Baseler et al., 2002) .
Expectations for efficacy based on a treatment-related increase in outer segment length or simply increased visual pigment content in cones with reduced outer segment length may have to be recalibrated adding in the uncertainty of a possible post-receptoral developmental acuity disturbance.
Adding further to the complexity of developing and interpreting outcomes of a BCM clinical trial are the constraints that light aversion imposes on psychophysical testing of cone function, except for measurement of absolute thresholds using chromatic stimuli. A potentially quantifiable parameter that may decrease with treatment is light aversion (for example, Gawande et al., 1989 ) and this may provide not only an outcome measure but also a practical benefit to these patients who otherwise show varying degrees of disability under ambient lights.
Figure Legends
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Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy (doi: 10.1089/hum.2013.153) This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. sensitive opsin (OPN1LW) gene (dark gray arrow), and one or more middle-wavelength sensitive opsin (OPN1MW) genes (light gray arrow) arranged in a head-to-tail tandem repeat. Subscript "n" indicates one or more M pigment genes. L/M hybrid genes are shown (dark/light gray arrow). Each gene is preceded by a proximal promoter and the expression is controlled by a single locus control region (LCR) upstream of the array (black rectangle). Genetic analyses implied that the OPN1LW/OPN1MW gene clusters in all patients of this study were impaired by large deletions affecting the locus control region (LCR) and varying parts of the opsin gene cluster with the exception of Family 1 which had an intact LCR with a deletion spanning the OPN1LW and OPN1MW genes. Brackets demarcate the deletions; deletion size is indicated inside the brackets where defined. assuming S-cones comprise between 6-7% of the total normal cone population. In all cases, the patients with BCM had a lower cone density than that seen in normals, but a higher total cone density than would be expected for just the S cone submosaic, indicating at least some of the cones in these images are L/M cones.
Page 36 of 47
Human Gene Therapy Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy (doi: 10.1089/hum.2013.153) This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 
Human Gene Therapy
Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy (doi: 10.1089/hum.2013.153) This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. restriction fragment length polymorphism (RFLP) in exon 4 via BstUI analysed for the c.607T>C p.C203R mutation, while the RFLP in exon 5 via RsaI addressed the dimorphism at amino acid position 277p.Y277 being specific for the OPN1LW gene, and p.F277 for the OPN1MW gene. Second-tier testing (not necessary for the cases reported in this study) analyzed for other deleterious point mutations or haplotypes in cases with either single or multiple structurally intact gene copies.
Primers and conditions are available upon request.
In Method 2 (performed by RH, ZA in 7 of the 20 patients; Patients 5, 6, [11] [12] [13] 17, 18) there was sequencing of the LCR, promoter, and OPN1MW and OPN1LW genes. Primers flanking 300-500bp segments were designed to amplify exons, the immediate 500bp of 5' promoter, the 37bp core LCR sequence, interval sequences spaced every ~1kb from the promoter to ~9kb upstream of the first opsin gene. PCR and DNA sequencing was performed as described (Jaworek et al., 2012) . Briefly, PCR products were amplified using 50ng DNA, with standard PCR reagents (Genscript) or AmpliTaq gold (Invitrogen), on an ABI Veriti Thermocycler (Applied Biosystems, Austin, TX). A portion of amplified products were electrophoresed and measured on a 2% agarose gel. PCR products were precipitated and sequencing PCR performed using BigDye Terminator Ready Reaction Mix (ABI Biosystems). PCR primer sequences and conditions are available upon request. To evaluate for deletions, the presence or absence of PCR products was checked -spaced every ~1kb of the 9kb region upstream of the first opsin gene. Deletion size was estimated by the absence of sequential PCR products (assumed to be encompassed by the deletion). To confirm the absence Page 40 of 47
Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy (doi: 10.1089/hum.2013.153) of the LCR, three overlapping primer pairs were designed to amplify the core 37kb segment and surrounding LCR. Deletion endpoints were mapped by designing forward and reverse primers flanking the region of the absent PCR products. Real time PCR (RT-PCR) was used to determine the number of genes in the array, and the order or OPN1LW and OPN1MW genes was determined . Briefly, a quantitative RT-PCR assay was employed to estimate the relative ratio of first versus downstream genes in the X-chromosome opsin gene arrays.
Quantitative RT-PCR was also used to estimate the relative ratio of L to M genes in each X-chromosome array.
Method 3 (performed by JCG, AJH in P14) has been described (Gardner et al., 2010) .
In Vivo Microscopy of Human Retina.
Cross-sectional images of the retina were obtained with a spectral-domain optical coherence tomography (SD-OCT) instrument (RTVue-100, Optovue Inc., Fremont, CA). Overlapping, non-averaged, 9 mm-length scans were used to study the retina along the vertical meridian through the fovea. Raster scans (6x6 mm, 101 lines with 513 longitudinal reflectivity profiles [LRPs] each) centered at the fovea provided high density coverage of the macula. Scans were analyzed with custom programs (MatLab 7.5; MathWorks, Natick, MA). For the outer retinal sublaminae, signal peak assignments were based on our previously published work (Aleman et al., 2008; Jacobson et al., 2009; Maeda et al., 2009; Cideciyan et al., 2011; Jacobson et al., 2013) and those of others (Hood et Zhang et al., 2011; Birch et al., 2013) consistent with hypotheses on the correspondence between OCT signals and histologically-defined layers (Huang et al., 1998; Jacobson et al., 2003; and interpretations of ultra-high resolution AO OCT scans . Specifically, outer retinal sublaminae were assumed to include: a) a hyperreflective layer at the outer plexiform layer (OPL); b) a hyporeflective layer at the outer nuclear layer (ONL); c) a hyperreflective layer at the outer limiting membrane (OLM); d) a hyperreflective layer near the junction of inner and outer segments possibly corresponding to the ellipsoid region of inner segments (ISe); e) a hyperreflective layer near the interface between cone outer segments (COS) and contact cylinder (extra-foveal) or apical processes (foveal) of the RPE; f) a hyperreflective layer near the interface between rod outer segments (ROS) and RPE apical processes; and g) a hyperreflective layer near the interface between basal RPE and Bruch membrane.
Layer (f) could merge into layer (e) and become a single layer at the foveola in normal subjects. ONL thickness was defined as the distance from (a) to (c), COS thickness from (d) to (e), and ROS thickness from (d) to (f). Normal subjects (n=22; ages 8 to 62 years) included a subset (n=15) with spherical errors +2 to -4 D, and another subset (n=7) with high myopia, -5 to-10 D.
Adaptive Optics Imaging of the Photoreceptor Mosaic.
A previously described adaptive optics scanning laser ophthalmoscope (AOSLO) was used to image each subject's photoreceptor mosaic . Image sequences of 150 frames were recorded at each retinal This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. location using a 775 nm or 796 nm superluminescent diode, and an internal fixation target was used to guide the subjects' fixation for imaging of different retinal locations. Intra-frame distortion due to the sinusoidal motion of the resonant optical scanner was estimated from images of a Ronchi ruling and subsequently removed by resampling each frame of the raw video over a square pixel grid. After desinusoiding, a reference frame with minimal intra-frame eye motion was manually selected from each image sequence for subsequent registration using a previously described strip-based registration method (Dubra and Harvey, 2010) .
Each frame was divided into strips and each strip was registered against the reference frame by finding the relative position that maximized the normalized cross-correlation between them (Dubra and Harvey, 2010) . The registered frames were then averaged to create a single high signal to noise image for each image sequence, with between 40 and 50 frames being averaged to produce the final image at each retinal location.
The registered images for each subject were combined into a single montage (Adobe Photoshop; Adobe Systems, Inc., San Jose, CA), which was then registered to an image of the fundus exported from the Cirrus HD-OCT system (Carl Zeiss Meditec, Dublin, CA). This was done to determine the absolute location of the individual images within the montage with respect to the fovea. Axial length measurements were obtained for all subjects using an IOL Master (Carl Zeiss, Inc, Dublin, CA USA). Normal subjects (n=17; ages 20 to 36 years; axial length 22.46-27.98 mm) were imaged as controls: 11 were imaged at 0.5 and 0.8 mm, four Page 43 of 47
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were imaged at 1.5 mm, one was imaged at all three parafoveal locations, and one was imaged at the foveal center and 0.5 and 0.8mm.
For 13 of the controls and two patients (P6, P11), cone density was measured at 0.5 and 0.8 mm superior to the fovea using manual selection of cones; and in five of the controls and one of the patients (P11), both cone and rod density was measured at 1.5 mm. In the parafovea, density was measured over an 80 µm x 80 µm sampling window, which was chosen because the cone mosaic was relatively sparse in the two patients, and it was necessary to use a sampling window large enough to avoid capturing local inhomogeneity of the residual cone mosaic.
Spectral Sensitivity Function.
Spectral sensitivity functions were measured in normals (n=3, ages 31-50) and BCM P15 using a modified perimeter with methods previously described (Cideciyan et al., 1997 (Cideciyan et al., , 2000 Jacobson et al., 2013) . In brief, a 1.7° (equivalent to ~0.5 mm on the retina) diameter, 200-ms duration test stimulus spectrally shaped by interference filters (7 nm to 12 nm full-width at half-maximum, depending on wavelength) was used. In normal subjects, stimuli were presented at 0.6 mm superior retina with the use of an offset dim fixation. In BCM, stimuli were presented at the center of four dim fixation lights. Thresholds are reported normalized to energy. Spectral sensitivity functions for rods, S and L/M cones are also shown in term of relative energy. Spectral sensitivity functions were recorded under dark-adapted conditions and on increasing levels of achromatic 
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backgrounds. Sensitivities were fit by eye with scotopic and photopic luminosity functions, and S cone spectral sensitivity function . Note that normal subtractive cone-cone interactions on brighter background lights cause relative reduction of the sensitivity to the 560 nm stimulus as compared to neighboring 500 and 600 nm samples (Sperling and Harwerth, 1971) . Detection of 440 nm target on 100 phot.cd/m 2 yellow background, or detectable S-cone ERG. f Electroretinography was performed in different laboratories with different electrode types, protocols and normal limits. N, within normal limits of the laboratory; N(b), borderline normal -reports indicated blink or nystagmus artifact, imperfect cooperation, head not completely within ganzfeld stimulus or other possible sources of reduced amplitude. A, abnormal.
